Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

Roberta Mazzieri, Ferdinando Pucci, Davide Moi, Erika Zonari, Anna Ranghetti, Alvise Berti, Letterio S. Politi, Bernhard Gentner, Jeffrey L. Brown, Luigi Naldini, Michele De Palma

Research output: Contribution to journalArticle

328 Citations (Scopus)

Abstract

Tumor-infiltrating myeloid cells convey proangiogenic programs that counteract the efficacy of antiangiogenic therapy. Here, we show that blocking angiopoietin-2 (ANG2), a TIE2 ligand and angiogenic factor expressed by activated endothelial cells (ECs), regresses the tumor vasculature and inhibits progression of late-stage, metastatic MMTV-PyMT mammary carcinomas and RIP1-Tag2 pancreatic insulinomas. ANG2 blockade did not inhibit recruitment of MRC1+ TIE2-expressing macrophages (TEMs) but impeded their upregulation of Tie2, association with blood vessels, and ability to restore angiogenesis in tumors. Conditional Tie2 gene knockdown in TEMs was sufficient to decrease tumor angiogenesis. Our findings support a model wherein the ANG2-TIE2 axis mediates cell-to-cell interactions between TEMs and ECs that are important for tumor angiogenesis and can be targeted to induce effective antitumor responses.

Original languageEnglish (US)
Pages (from-to)512-526
Number of pages15
JournalCancer Cell
Volume19
Issue number4
DOIs
StatePublished - Apr 12 2011
Externally publishedYes

Fingerprint

Angiopoietin-2
Myeloid Cells
Neoplasm Metastasis
Growth
Macrophages
Neoplasms
Endothelial Cells
Gene Knockdown Techniques
Insulinoma
Angiogenesis Inducing Agents
Cell Communication
Blood Vessels
Up-Regulation
Breast Neoplasms
Ligands

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells. / Mazzieri, Roberta; Pucci, Ferdinando; Moi, Davide; Zonari, Erika; Ranghetti, Anna; Berti, Alvise; Politi, Letterio S.; Gentner, Bernhard; Brown, Jeffrey L.; Naldini, Luigi; De Palma, Michele.

In: Cancer Cell, Vol. 19, No. 4, 12.04.2011, p. 512-526.

Research output: Contribution to journalArticle

Mazzieri, R, Pucci, F, Moi, D, Zonari, E, Ranghetti, A, Berti, A, Politi, LS, Gentner, B, Brown, JL, Naldini, L & De Palma, M 2011, 'Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells', Cancer Cell, vol. 19, no. 4, pp. 512-526. https://doi.org/10.1016/j.ccr.2011.02.005
Mazzieri, Roberta ; Pucci, Ferdinando ; Moi, Davide ; Zonari, Erika ; Ranghetti, Anna ; Berti, Alvise ; Politi, Letterio S. ; Gentner, Bernhard ; Brown, Jeffrey L. ; Naldini, Luigi ; De Palma, Michele. / Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells. In: Cancer Cell. 2011 ; Vol. 19, No. 4. pp. 512-526.
@article{d9956eba2720474aa730e037d145f4b1,
title = "Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells",
abstract = "Tumor-infiltrating myeloid cells convey proangiogenic programs that counteract the efficacy of antiangiogenic therapy. Here, we show that blocking angiopoietin-2 (ANG2), a TIE2 ligand and angiogenic factor expressed by activated endothelial cells (ECs), regresses the tumor vasculature and inhibits progression of late-stage, metastatic MMTV-PyMT mammary carcinomas and RIP1-Tag2 pancreatic insulinomas. ANG2 blockade did not inhibit recruitment of MRC1+ TIE2-expressing macrophages (TEMs) but impeded their upregulation of Tie2, association with blood vessels, and ability to restore angiogenesis in tumors. Conditional Tie2 gene knockdown in TEMs was sufficient to decrease tumor angiogenesis. Our findings support a model wherein the ANG2-TIE2 axis mediates cell-to-cell interactions between TEMs and ECs that are important for tumor angiogenesis and can be targeted to induce effective antitumor responses.",
author = "Roberta Mazzieri and Ferdinando Pucci and Davide Moi and Erika Zonari and Anna Ranghetti and Alvise Berti and Politi, {Letterio S.} and Bernhard Gentner and Brown, {Jeffrey L.} and Luigi Naldini and {De Palma}, Michele",
year = "2011",
month = "4",
day = "12",
doi = "10.1016/j.ccr.2011.02.005",
language = "English (US)",
volume = "19",
pages = "512--526",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

AU - Mazzieri, Roberta

AU - Pucci, Ferdinando

AU - Moi, Davide

AU - Zonari, Erika

AU - Ranghetti, Anna

AU - Berti, Alvise

AU - Politi, Letterio S.

AU - Gentner, Bernhard

AU - Brown, Jeffrey L.

AU - Naldini, Luigi

AU - De Palma, Michele

PY - 2011/4/12

Y1 - 2011/4/12

N2 - Tumor-infiltrating myeloid cells convey proangiogenic programs that counteract the efficacy of antiangiogenic therapy. Here, we show that blocking angiopoietin-2 (ANG2), a TIE2 ligand and angiogenic factor expressed by activated endothelial cells (ECs), regresses the tumor vasculature and inhibits progression of late-stage, metastatic MMTV-PyMT mammary carcinomas and RIP1-Tag2 pancreatic insulinomas. ANG2 blockade did not inhibit recruitment of MRC1+ TIE2-expressing macrophages (TEMs) but impeded their upregulation of Tie2, association with blood vessels, and ability to restore angiogenesis in tumors. Conditional Tie2 gene knockdown in TEMs was sufficient to decrease tumor angiogenesis. Our findings support a model wherein the ANG2-TIE2 axis mediates cell-to-cell interactions between TEMs and ECs that are important for tumor angiogenesis and can be targeted to induce effective antitumor responses.

AB - Tumor-infiltrating myeloid cells convey proangiogenic programs that counteract the efficacy of antiangiogenic therapy. Here, we show that blocking angiopoietin-2 (ANG2), a TIE2 ligand and angiogenic factor expressed by activated endothelial cells (ECs), regresses the tumor vasculature and inhibits progression of late-stage, metastatic MMTV-PyMT mammary carcinomas and RIP1-Tag2 pancreatic insulinomas. ANG2 blockade did not inhibit recruitment of MRC1+ TIE2-expressing macrophages (TEMs) but impeded their upregulation of Tie2, association with blood vessels, and ability to restore angiogenesis in tumors. Conditional Tie2 gene knockdown in TEMs was sufficient to decrease tumor angiogenesis. Our findings support a model wherein the ANG2-TIE2 axis mediates cell-to-cell interactions between TEMs and ECs that are important for tumor angiogenesis and can be targeted to induce effective antitumor responses.

UR - http://www.scopus.com/inward/record.url?scp=79953750307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953750307&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2011.02.005

DO - 10.1016/j.ccr.2011.02.005

M3 - Article

C2 - 21481792

AN - SCOPUS:79953750307

VL - 19

SP - 512

EP - 526

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 4

ER -